Capers

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: heart inflammation immunity

Research Overview

Research on capers (the unopened flower buds of Capparis spinosa) has most heavily focused on their phytochemical composition and mechanistic bioactivity of key polyphenols, especially the flavonoids quercetin and kaempferol. Multiple lines of laboratory work characterize capers as a concentrated dietary source of these compounds and document antioxidant-related properties in chemical and cell-based assays, including radical-scavenging capacity and trapping of reactive carbonyl species (e.g., methylglyoxal/glyoxal) in extracts from fermented capers. A second well-studied area is mechanistic pharmacology: quercetin from capers has been shown in electrophysiology experiments to modulate KCNQ (Kv7) potassium channels (e.g., KCNQ1/KCNE1 and KCNQ2/3), providing a plausible molecular pathway by which quercetin-rich foods could influence cellular excitability and related physiological processes. Capers are also frequently discussed within the broader Mediterranean diet literature as a “functional” plant food rich in polyphenols, with attention to how processing (notably fermentation) may alter the biochemical profile and potential bioaccessibility.

The strongest evidence supports that capers contain high levels of bioactive polyphenols and that these molecules exert measurable biochemical and cellular effects under experimental conditions. Evidence is particularly consistent for antioxidant and carbonyl-trapping activity in vitro and for specific ion-channel modulation by quercetin in controlled model systems. In contrast, evidence directly linking caper consumption to clinical outcomes remains limited: health-related claims in the literature are largely based on mechanistic studies, preclinical models, and extrapolation from broader research on quercetin/kaempferol or Mediterranean dietary patterns. Human evidence relevant to capers is emerging but sparse; for example, dietary intervention work examining gut microbiome responses has included capers as one component among other foods, making it difficult to isolate caper-specific effects.

Key gaps include well-controlled human studies that quantify realistic intake, standardize caper preparations (fresh vs. salted/fermented; brined vs. oil-packed), and measure validated biomarkers of exposure and effect. More research is also needed on bioavailability and metabolism of caper polyphenols in typical culinary contexts (including the impact of fermentation and salt), dose–response relationships, and inter-individual variability (e.g., microbiome-dependent metabolism). Finally, while mechanistic findings (e.g., KCNQ modulation) are compelling, translation requires studies that connect these molecular effects to physiological endpoints in humans, alongside safety and dietary context considerations for regular consumption.

1. What conditions has Capers been studied for?

  • Cancer-related mechanisms and risk (indirect evidence): Research on capers often focuses on their high content of flavonols such as kaempferol and quercetin, compounds studied for anti-cancer mechanisms (e.g., effects on apoptosis, cell-cycle regulation, EMT markers, and PI3K/Akt signaling) largely in experimental models.

  • Cardiovascular health (supportive/associative evidence): Reviews of Mediterranean-diet plants describe capers’ kaempferol and quercetin as bioactives that may support cardiovascular health, largely based on mechanistic and broader polyphenol literature rather than caper-specific clinical trials.

  • Neuroprotection (compound-driven evidence): Quercetin—abundant in capers—has been studied for neuroprotective actions in preclinical models of neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, Huntington’s, ALS), with limited clinical exploration overall.

  • Gut microbiome modulation (human intervention evidence, mixed-food context): A randomized controlled dietary intervention in older adults tested groups consuming strawberries and some groups consuming capers in olive oil, assessing changes in gut microbial composition and diversity.

  • Oxidative stress and “carbonyl stress” chemistry (lab/food science evidence): Studies of fermented capers evaluated antioxidant activity (DPPH, ABTS, ORAC) and the ability of extracts to trap reactive carbonyls such as methylglyoxal and glyoxal (in vitro).

  • Ion-channel modulation relevant to excitability (mechanistic evidence): Cell studies found caper extract and quercetin modulate KCNQ (Kv7) potassium channels (including KCNQ1/KCNE1 and KCNQ2/3), a mechanistic pathway potentially relevant to cardiac and neuronal excitability.

2. Does it work in treating those conditions? Summarize the evidence.

  • Cancer: Evidence for “treatment” with capers is not established. The strongest claims in the literature are mechanistic and preclinical, largely centered on kaempferol and quercetin. Reviews describe anti-cancer mechanisms for kaempferol (e.g., apoptosis, G2/M arrest, EMT-marker downregulation, PI3K/Akt pathway effects) and note associations between kaempferol-rich foods and lower risk of some cancers, but they also emphasize the need for further preclinical and clinical studies before public-health recommendations.

  • Cardiovascular health: Reviews of Mediterranean-diet plants describe capers’ flavonols as supportive of cardiovascular health, but this is largely inferential (based on known bioactivities of polyphenols) rather than demonstrated caper-specific clinical efficacy for treating cardiovascular disease.

  • Neurodegenerative diseases: Quercetin has extensive preclinical neuroprotective literature and comparatively limited clinical research as a nutraceutical; reviews highlight challenges such as bioavailability and note that nanoformulations are mostly still preclinical. This does not demonstrate that eating capers treats neurodegenerative disease.

  • Gut microbiome: In a 10-week randomized controlled trial in older adults, the group with the highest strawberry intake without capers in olive oil showed microbiome changes linked to improved health, indicating that benefits observed in that trial cannot be attributed to capers; capers were part of some intervention arms, but the clearest reported signal was in the arm without capers.

  • Oxidative/carbonyl stress (in vitro): Fermented caper extracts showed antioxidant activity in multiple assays and demonstrated methylglyoxal/glyoxal trapping capacity in lab testing. These findings support biochemical potential but do not prove clinical treatment effects in humans.

  • Ion-channel effects (mechanistic): Caper extract hyperpolarized cells expressing KCNQ channels, and quercetin potentiated several KCNQ channel currents (with a distinct pattern across channel subtypes). This is a plausible mechanistic basis for physiological effects, but it is not clinical evidence of treatment.

3. What health benefits does it have?

  • Rich source of polyphenols (especially flavonols): Chemical profiling studies identify rutin, quercetin, kaempferol, myricetin, isorhamnetin, and phenolic acids (e.g., sinapic, p-coumaric, ferulic, vanillic). Quantification work reports high total polyphenols and flavonoids in raw capers, with strong antioxidant activity correlated with phenolic content.

  • Antioxidant potential (lab measures): Multiple studies report strong antioxidant activity in caper extracts using assays such as DPPH, ABTS, FRAP, and ORAC, with raw capers often showing the highest activity among raw/processed forms.

  • Bioaccessibility of phenolics after digestion (in vitro digestion model): Research comparing raw vs pickled capers found pickling did not materially reduce total phenolics/flavonoids or baseline antioxidant measures, and reported relatively high in vitro bioaccessibility of total phenolics (on the order of roughly three-quarters). Antioxidant activity measures decreased after simulated digestion, suggesting that “antioxidant capacity” measured in the jar does not fully translate through digestion.

  • Potential cardiometabolic and anti-inflammatory relevance (indirect): Reviews of Mediterranean-diet plants attribute anti-inflammatory and cardioprotective potential to polyphenol-rich foods, and specifically highlight capers’ kaempferol and quercetin as candidate bioactives. This is supportive context rather than proof of clinical benefit from capers alone.

  • Mechanistic plausibility for effects on cellular excitability: Cell studies show quercetin (abundant in capers) can modulate KCNQ potassium channels, providing a mechanistic pathway by which quercetin-rich foods could influence physiological processes (though real-world impact from dietary capers remains uncertain).

4. Does it have any downsides or side effects?

  • High sodium in common preparations: Capers are commonly consumed brined/salt-fermented. While the studies summarized here focus on polyphenols and do not quantify sodium-related outcomes, high-salt foods can be a concern for people managing blood pressure or sodium intake. This is a practical dietary downside of typical caper products.

  • Processing can change polyphenol levels: Studies comparing raw and processed capers/caperberries found raw forms tend to have the highest polyphenol/flavonoid concentrations, with fermented caperberries among the lowest. This is not a “side effect,” but it means the health-relevant compounds may vary substantially by product type and processing.

  • Uncertain clinical relevance and dosing: Many reported benefits are based on in vitro assays, cell experiments, and reviews of isolated compounds (kaempferol/quercetin). These do not reliably predict side effects or benefits at typical dietary intakes.

  • Potential for drug-like biological activity (theoretical): Because quercetin can modulate ion channels in cell studies, it underscores that bioactives in foods can have pharmacology. However, the research summarized does not establish clinically meaningful adverse effects from dietary capers.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

  • Ion-channel genetics (mechanistic relevance, not proven clinically): Cell research shows quercetin potentiates several KCNQ potassium channels (including KCNQ1/KCNE1 and KCNQ2/3) but not KCNQ5, and caper extract hyperpolarizes cells expressing KCNQ1 or KCNQ2/3. Because KCNQ genes are clinically important (e.g., KCNQ1 in cardiac electrophysiology; KCNQ2/3 in neuronal excitability), this raises a plausible pharmacogenomic question: individuals with certain KCNQ variants could, in theory, respond differently to quercetin-rich foods. However, the evidence here is mechanistic and cellular, not human genotype-stratified outcomes.

  • Nutrigenomics more broadly (conceptual): Reviews of Mediterranean-diet plants discuss nutrigenomic effects of plant bioactives in general, but do not provide caper-specific, genotype-based clinical findings. At present, there is no clear evidence that specific genetic variants make capers distinctly beneficial or harmful in typical dietary use.

References

  1. Kaempferol: A Key Emphasis to Its Anticancer Potential.
    Muhammad Imran, Bahare Salehi, Javad Sharifi-Rad, Tanweer Aslam Gondal, Farhan Saeed, Ali Imran, Muhammad Shahbaz, Patrick Valere Tsouh Fokou, Muhammad Umair Arshad, Haroon Khan, Susana G Guerreiro, Natália Martins, Leticia M Estevinho (2019) - Molecules (Basel, Switzerland)
  2. Drought-Adapted Mediterranean Diet Plants: A Source of Bioactive Molecules Able to Give Nutrigenomic Effects per sè or to Obtain Functional Foods.
    Silvia La Scala, Flores Naselli, Paola Quatrini, Giuseppe Gallo, Fabio Caradonna (2024) - International journal of molecular sciences
  3. Expanding Arsenal against Neurodegenerative Diseases Using Quercetin Based Nanoformulations: Breakthroughs and Bottlenecks.
    Sukriti Vishwas, Rajesh Kumar, Rubiya Khursheed, Arya Kadukkattil Ramanunny, Rajan Kumar, Ankit Awasthi, Leander Corrie, Omji Porwal, Mohammed F Arshad, Mohammed Kanan Alshammari, Abdulrahman A Alghitran, Ashwaq N Qumayri, Saif M Alkhaldi, Abdulaziz Khalaf Alshammari, Dinesh Kumar Chellappan, Gaurav Gupta, Trudi Collet, Jon Adams, Kamal Dua, Monica Gulati, Sachin Kumar Singh (2023) - Current neuropharmacology
  4. Statement on the revised targeted risk assessment for certain maximum residue levels for nicotine.
  5. Functional foods in Mediterranean diet: exploring the functional features of vegetable case-studies obtained also by biotechnological approaches.
    Anna Rita Bavaro, Annamaria Tarantini, Angelica Bruno, Antonio F Logrieco, Antonia Gallo, Giovanni Mita, Francesca Valerio, Gianluca Bleve, Angela Cardinali (2024) - Aging clinical and experimental research
  6. Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people.
    Franziska Meiners, Bernd Kreikemeyer, Patrick Newels, Ingmar Zude, Michael Walter, Alexander Hartmann, Daniel Palmer, Georg Fuellen, Israel Barrantes (2025) - Microbiology spectrum
  7. Phytochemistry, Biological Activities, Therapeutic Potential, and Socio-Economic Value of the Caper Bush (Capparis Spinosa L.).
    Ayoub Kdimy, Meryem El Yadini, Abdelkarim Guaadaoui, Ilhame Bourais, Souad El Hajjaji, Hoang V Le (2022) - Chemistry & biodiversity
  8. The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator.
    Kaitlyn E Redford, Geoffrey W Abbott (2020) - Communications biology
  9. Nutraceutical Value of Pantelleria Capers (Capparis spinosa L.).
    Fabrizia Lo Bosco, Valeria Guarrasi, Marta Moschetti, Maria Antonietta Germanà, Daniela Butera, Federica Corana, Adele Papetti (2019) - Journal of food science
  10. Bioaccessibility of phenolic compounds and antioxidant activity in raw and pickled capers.
    Müzeyyen Berkel Kaşıkçı, Neriman Bağdatlıoğlu (2024) - Journal of food science and technology
  11. Pest categorisation of
    Claude Bragard, Paula Baptista, Elisavet Chatzivassiliou, Francesco Di Serio, Paolo Gonthier, Josep Anton Jaques Miret, Annemarie Fejer Justesen, Christer Sven Magnusson, Panagiotis Milonas, Juan A Navas-Cortes, Stephen Parnell, Roel Potting, Philippe Lucien Reignault, Emilio Stefani, Hans-Hermann Thulke, Wopke Van der Werf, Antonio Vicent Civera, Jonathan Yuen, Lucia Zappalà, Jean-Claude Grégoire, Chris Malumphy, Virag Kertesz, Andrea Maiorano, Alan MacLeod (2022) - EFSA journal. European Food Safety Authority
  12. Phenolic Composition and Phytochemical Analysis of Moroccan Raw and Processed Capparis spinosa Buds and Berries.
    Nidal El Amri, Rachida Chabir, Rabie Kachkoul, Abdellatif Bour (2025) - Chemistry & biodiversity


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!